Greg Pyszczymuka serves as Executive at AYTU BIOPHARMA, INC, where they oversee executive responsibilities. Since joining the company, Greg Pyszczymuka has executed 9 insider transactions totaling $46.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 3, 2025 involved receiving (via award) 12,500 shares valued at $0.
Greg Pyszczymuka currently holds 36,102 shares of AYTU BIOPHARMA, INC (AYTU), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Greg Pyszczymuka has been a net buyer of AYTU stock. They have purchased $46.4K and sold $0 worth of shares.
Greg Pyszczymuka's most recent insider trade was on Oct 3, 2025, when they sold 12,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 31, 2024 | AYTU | $0 | Option Exercise | 208 | $N/A | Discretionary |
| Dec 31, 2023 | AYTU | $0 | Option Exercise | 209 | $N/A | Discretionary |
| Sep 30, 2023 | AYTU | $0 | Option Exercise | 208 | $N/A | Discretionary |
| Jun 30, 2023 | AYTU | $0 | Option Exercise | 208 | $N/A | Discretionary |
| Jun 16, 2023 | AYTU | $22.4K | Purchase | 12,000 | $1.87 | Discretionary |
| Apr 25, 2023 | AYTU | $0 | Option Exercise | 833 | $N/A | Discretionary |
| Dec 19, 2022 | AYTU | $24.0K | Purchase | 100,000 | $0.24 | Discretionary |